Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few ...

First-in-class oral therapy ATR-258 mimics the effects of exercise - driving fat loss, increasing muscle, and improving metabolism - with broad potential as a novel treatment for muscle-sparing ...

Trendlines add that the El Salvador trial was designed to demonstrate the safety and efficacy of this approach.

Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

(RTTNews) - Akari Therapeutics, Plc (Nasdaq: AKTX) yesterday announced that it has initiated GMP manufacturing of its lead antibody-drug conjugate (ADC), AKTX-101, marking a pivotal step toward its ...

The combination of placenta-derived stem cells (PMSCs) with standard in utero repair for severe spina bifida appears feasible and safe, with no cell-related adverse events observed at birth, a ...

First-in-Human(FIH)Trialat36Months: PhaseI/IITrialat3Months: 37% and 36% reduction in mean IOP with 98% and 96% of patients off topical IOP-lowering drops in 78 mcg and 39 mcg dose groups, ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a disease-modifying treatment for amyotrophic lateral sclerosis / motor neuron disease ...